CARINA MESSURA: Open Payments
NPI 1609527746 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 173 payments from 19 companies in 2025. Trend: 2023 $3,331 · 2024 $4,284 · 2025 $2,753
Food & beverage: $2,753
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 30 | $578 |
| ABBVIE INC. | 22 | $346 |
| Otsuka America Pharmaceutical, Inc. | 20 | $329 |
| E.R. Squibb & Sons, L.L.C. | 18 | $241 |
| Supernus Pharmaceuticals, Inc. | 16 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $192 |
| Alkermes, Inc. | 11 | $164 |
| Axsome Therapeutics, Inc. | 11 | $159 |
| Janssen Pharmaceuticals, Inc | 5 | $108 |
| Teva Pharmaceuticals USA, Inc. | 6 | $88 |
Products named: HETLIOZ, VRAYLAR, REXULTI, COBENFY, Qelbree, CAPLYTA, ARISTADA, Auvelity.
Industry payments across NC — which companies pay providers there.
